This inventor holds 7 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 6 EPO patents. Top assignees: Kyowa Hakko Kirin Co., Limited, Kyowa Kirin Co., Ltd.. Active years: 2015-2023.
Company Filing History:
Years Active: 2015-2023
Title: The Innovative Contributions of Shintaro Hosoe
Introduction
Shintaro Hosoe, a notable inventor based in Tokyo, Japan, has made significant contributions to the field of biotechnology. With a total of seven patents to his name, Hosoe's work primarily focuses on innovations involving nucleic acids and lipid-based delivery systems.
Latest Patents
Hosoe's recent inventions include a nucleic acid-containing lipid nanoparticle. This invention provides a unique formulation comprising an analog of a fatty acid ester of glycerol and a nucleic acid, which is notable for its resistance to hydrolysis by lipase. Another noteworthy patent is for a compound usable as a cationic lipid, designed to facilitate the introduction of nucleic acids into cells, enhancing the efficiency of gene delivery systems.
Career Highlights
Throughout his career, Shintaro Hosoe has worked with notable companies, including Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. His expertise and innovative spirit have allowed him to push the boundaries of scientific exploration and application in biotechnology.
Collaborations
Hosoe has collaborated with esteemed colleagues, such as Tomoyuki Naoi and Takeshi Kuboyama. These partnerships have contributed to the development and enhancement of his inventions, fostering a collaborative spirit within the research community.
Conclusion
Shintaro Hosoe continues to be a pivotal figure in the realm of innovative biotechnology, with his patents reflecting a commitment to advancing scientific knowledge and application. His work not only stands as a testament to his ingenuity but also paves the way for future advancements in nucleic acid delivery systems.